The global topical antibiotics market is expected to grow at a significant CAGR during the forecast period (2021-2027).  Topical antibiotics are applied to a specific area of the skin to eliminate infections. When compared to systemic distribution, topical antibiotics have a variety of advantages in the treatment of skin infections. Skin and soft tissue infections (SSTIs) are one of the most frequent disorders among people, involving microbial invasion of the skin and underlying soft tissues infections. The majority of these infections are small and persistent, creating discomfort. These infections are caused by a wide variety of bacteria, including Staphylococcus aureus (S. aureus), Streptococcus viridians, and Streptococcus pyogenes. Patients with inadequate hygiene, weakened immune systems, or close contact with patients suffering from skin illnesses are more likely to be affected.

Topical antibiotics have grown in popularity as a treatment and management option for a variety of medical disorders. The use of topical antibiotics to fight bacterial skin infection has shown a constant rise over the last few decades, with indications such as the skin, eye, and Bromhidrosis. Drug developers and other stakeholders across the globe, in the topical antibiotics market, are focusing more on tackling various difficulties linked to the use of topical antibiotics, such as the rising rate of bacterial resistance and local hypersensitivity, at the moment. The increasing mix of medications with diverse chemical moieties for treating various skin infections is a major driver for topical antibiotics. Owing to the increased awareness of OTC antibiotic drugs, the market for topical antibiotics has grown substantially. Furthermore, the introduction of novel and upcoming medicines such as ebselen and retapamulin will significantly contribute to the growth of the global topical antibiotics market during the forecast period.

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered- 

o By Drugs

o By Indication

o By Distribution Channel 

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape:  Pfizer Inc., Mylan N.V., and GlaxoSmithKline plc, among others. 

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How are players addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Topical Antibiotics Market Report by Segment

By Drugs

• Bacitracin
• Polymixin B
• Neomycin
• Ciprofloxacin
• Others

By Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Global Topical Antibiotics Market by Region

North America       

• US

• Canada

Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia-Pacific    

• China

• Japan

• India

• Rest of Asia-Pacific

Rest of the World

• Latin America

• Middle East and Africa